Tetragon - Extracting Alpha. Compounding value.

At Tetragon, we have been investing in alternative assets for over 20 years.

Through our innovative investment approach, we extract alpha and seek to compound value over time.

Our portfolio spans a diversified range of alternatives, from idiosyncratic, one-off opportunities to long-term partnerships with entrepreneurial CIOs on our Tetragon Partners platform. Through our platform we buy, launch and build both niche and scalable asset management businesses and strategies, ranging from startups to over $16 billion in AUM.⁽¹⁾

Our flexible investment mandate is backed by $3.8 billion in permanent capital from our listed closed-ended fund Tetragon Financial Group.

We are headquartered in London and New York.

Find out more

Our exposure

We and our partners invest
across a range of alternatives

Life Sciences

Breakthrough therapies in immune-mediated diseases, cardiometabolic and renal conditions, neurological disorders, rare diseases and precision oncology.

Infrastructure

Social infrastructure, transportation, renewable power, environmental services, network utilities and data infrastructure.

Digital assets

Financial infrastructure and blockchain technology solutions.

Applied Data Science

Combining private equity investment alongside deployment of AI systems to create and capture value in portfolio companies.

Mining and Resource Finance

Gold, nickel, copper and lithium exploration in predominantly developed economies.

Private Credit

CLOs, CLO equity and legal assets.

GP Stakes in Asset Management Businesses

Buying, launching and building alternative asset management businesses.

Real Estate

Offices, industrial, multi-residential, retail and hospitality properties across North America, Europe and Asia.

“At Tetragon, we have built a firm that gives us the flexibility to explore investment opportunities that many others simply can’t. We have a proven ability to compound investment growth and return value.”

Paddy Dear
Tetragon Co-Founder